Olaris
Framingham
About Olaris
Olaris is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging our CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, we harness the power of the body’s own communication system to discover and develop our pipeline of myOLARIS™ precision diagnostics. To learn more, visit https://www.myolaris.com/ The company was founded in 2013 and is headquartered in Framingham, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2025)
- Website: myolaris.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/olaris-199261 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.